News
A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...
"The reduction in stroke risk ranged between 54% to 73%, depending on the season and statistical method applied," the authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results